Hepcvel 400mg/100mg Tablet is a combination of Sofosbuvir 400mg and Velpatasvir 100mg used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Cipla Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Ledifos Tablet is a combination of Ledipasvir (90mg) and Sofosbuvir (400mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Ledipasvir (90mg) and Sofosbuvir (400mg) |
| Manufacturer | Hetero Healthcare Limited |
| Packing | 28 Tablets in a Bottle |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Myhep All Tablet is a fixed-dose combination of Velpatasvir 100mg and Sofosbuvir 400mg used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Mylan Pharmaceuticals Pvt Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Resof Total Tablet is a fixed-dose combination tablet containing Sofosbuvir (400mg) and Velpatasvir (100mg), used for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Sofosbuvir (400mg) + Velpatasvir (100mg) |
| Manufacturer | Dr. Reddy’s Laboratories Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Sofocure V tablet is a combination antiviral medicine containing Sofosbuvir 400mg and Velpatasvir 100mg. It is used for the treatment of chronic Hepatitis C virus (HCV) infection across all six genotypes.
| Composition | Sofosbuvir 400mg + Velpatasvir 100mg |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C |
| Expiry | December 2027 |
Velakast Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used for the treatment of chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Velasof 400 mg/100 mg Tablet is a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), used to treat chronic hepatitis C virus (HCV) infection in adults.
| Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
| Manufacturer | Hetero Healthcare Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Hepcinat 400 mg contains Sofosbuvir and is used to treat chronic Hepatitis C virus (HCV) infection in adults and children (aged 3 and above).
| Composition | Sofosbuvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
